临床放射学杂志
臨床放射學雜誌
림상방사학잡지
JOURNAL OF CLINICAL RADIOLOGY
2001年
4期
246-250
,共5页
郑蔚巍%周康荣%陈祖望%沈继章%陈财忠%张澍杰
鄭蔚巍%週康榮%陳祖望%瀋繼章%陳財忠%張澍傑
정위외%주강영%진조망%침계장%진재충%장주걸
肝%局灶性病变%超顺磁性氧化铁%诊断
肝%跼竈性病變%超順磁性氧化鐵%診斷
간%국조성병변%초순자성양화철%진단
目的探讨超顺磁性氧化铁(SPIO)增强MRI在肝脏局灶性病变的定性能力。材料与方法 43例怀疑肝占位者经常规MRI和Gd-DTPA增强后1~7后,行SPIO增强检查。其中31例经手术病理证实,12例经随访、实验室生化检查及临床资料证实。分析平扫MRI及SPIO增强后病灶的信号变化,并与Gd-DTPA动态增强结果相对照。结果 43例共12种病变,单发病灶21例,多发病灶22例。包括原发性肝细胞肝癌22例,血管瘤5例,囊肿4例,转移性肝癌5例,肝硬化结节4例,局灶性结节增生(FNH)5例,其他病变6例。22例多发病灶中有8例合并1或2种病变。SPIO增强后,肝细胞肝癌T1WI为等或略高信号,T2WI为较高信号;血管瘤T1WI为较高信号,T2WI信号同平扫为高信号;囊肿T1WI、T2WI信号无改变;肝硬化结节T2WI为等信号同正常肝实质;FNH T2WI信号明显下降。其余病变的诊断SPIO增强不具有特征性,须与Gd-DTPA动态增强相结合。结论 SPIO具有一定的定性能力,与Gd-DTPA增强相结合,可帮助提高肝局灶性病变诊断和鉴别诊断的准确性。
目的探討超順磁性氧化鐵(SPIO)增彊MRI在肝髒跼竈性病變的定性能力。材料與方法 43例懷疑肝佔位者經常規MRI和Gd-DTPA增彊後1~7後,行SPIO增彊檢查。其中31例經手術病理證實,12例經隨訪、實驗室生化檢查及臨床資料證實。分析平掃MRI及SPIO增彊後病竈的信號變化,併與Gd-DTPA動態增彊結果相對照。結果 43例共12種病變,單髮病竈21例,多髮病竈22例。包括原髮性肝細胞肝癌22例,血管瘤5例,囊腫4例,轉移性肝癌5例,肝硬化結節4例,跼竈性結節增生(FNH)5例,其他病變6例。22例多髮病竈中有8例閤併1或2種病變。SPIO增彊後,肝細胞肝癌T1WI為等或略高信號,T2WI為較高信號;血管瘤T1WI為較高信號,T2WI信號同平掃為高信號;囊腫T1WI、T2WI信號無改變;肝硬化結節T2WI為等信號同正常肝實質;FNH T2WI信號明顯下降。其餘病變的診斷SPIO增彊不具有特徵性,鬚與Gd-DTPA動態增彊相結閤。結論 SPIO具有一定的定性能力,與Gd-DTPA增彊相結閤,可幫助提高肝跼竈性病變診斷和鑒彆診斷的準確性。
목적탐토초순자성양화철(SPIO)증강MRI재간장국조성병변적정성능력。재료여방법 43례부의간점위자경상규MRI화Gd-DTPA증강후1~7후,행SPIO증강검사。기중31례경수술병리증실,12례경수방、실험실생화검사급림상자료증실。분석평소MRI급SPIO증강후병조적신호변화,병여Gd-DTPA동태증강결과상대조。결과 43례공12충병변,단발병조21례,다발병조22례。포괄원발성간세포간암22례,혈관류5례,낭종4례,전이성간암5례,간경화결절4례,국조성결절증생(FNH)5례,기타병변6례。22례다발병조중유8례합병1혹2충병변。SPIO증강후,간세포간암T1WI위등혹략고신호,T2WI위교고신호;혈관류T1WI위교고신호,T2WI신호동평소위고신호;낭종T1WI、T2WI신호무개변;간경화결절T2WI위등신호동정상간실질;FNH T2WI신호명현하강。기여병변적진단SPIO증강불구유특정성,수여Gd-DTPA동태증강상결합。결론 SPIO구유일정적정성능력,여Gd-DTPA증강상결합,가방조제고간국조성병변진단화감별진단적준학성。
Objective To evaluate superparamagnetic iron oxide (SPIO) enhanced MRI in the diagnosis of focal hepatic lesions. Materials and Methods This study included 43 cases with suspected focal hepatic lesions. All patients underwent plain and Gd-DTPA enhanced MRI, SPIO enhanced MRI was taken 1~7 days later. The diagnosis was pathologically confirmed in 31 cases, while clinically proved in the other 12 cases. The changes in signal intensity (SI) of the lesions before and after SPIO enhancement were analyzed and compared with that of Gd-DTPA enhancement. Results Multiple lesions were seen in 22 cases, of which 8 cases were accompanied by one or two diseases. Hepatic lesions included following diseases: primary hepatocellular carcinoma (HCC, n=22), hemangioma (n=5), cyst (n=4), metastases (n=5), cirrhotic nodule (n=4), focal nodular hyperplasia (FNH, n=5), and miscellaneous diseases (n=6). After SPIO enhancement, some lesions showed certain changes in SI. For HCC, the lesions displayed iso- or slightly hyperintense on T1WI and moderate hyperintense on T2WI. For hemangioma, the lesions showed moderate hyperintense on T1WI and marked hyperintense on T2WI similar to that on plain scan. For cyst, no changes in SI were seen on both T1WI and T2WI, while cirrhotic nodules demonstrated iso-intense on T2WI same as the normal hepatic parenchyma. The SI of FNH decreased significantly on T2WI. For the other 6 lesions no specific menifastations were found after SPIO enhancement, and the diagnosis had to be based on the findings with Gd-DTPA dynamic enhancement. Conclusion A combination of SPIO enhancement and the Gd-DTPA dynamic enhancement can improve the accuracy in diagnosing focal hepatic lesions.